MECHANISM OF ACTION OF 4-AMINOPYRIDINE IN THE SYMPTOMATIC TREATMENT OF MULTIPLE-SCLEROSIS

被引：16
|
作者：
DAVIS, FA [1 ]
STEFOSKI, D [1 ]
QUANDT, FN [1 ]
机构：
[1] RUSH UNIV,DEPT PHYSIOL,CHICAGO,IL 60612
来源：
ANNALS OF NEUROLOGY | 1995年 / 37卷 / 05期
关键词：
D O I：
10.1002/ana.410370524
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：684 / 684
页数：1
相关论文
共 50 条
  • [21] Fampridine -: 4-aminopyridine -: Neurelan® -: Treatment of multiple sclerosis -: Treatment of spinal cord injury
    不详
    DRUGS OF THE FUTURE, 2001, 26 (02) : 178 - 180
  • [22] Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)
    Andrew D. Goodman
    Robert Thompson Stone
    Neurotherapeutics, 2013, 10 : 106 - 110
  • [23] The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis
    Miyoshi, T
    Fujihara, K
    NEUROLOGY, 1998, 50 (04) : A146 - A147
  • [24] The effects of 4-aminopyridine on motor evoked potentials in multiple sclerosis
    Fujihara, K
    Miyoshi, T
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 159 (01) : 102 - 106
  • [25] Chronic 4-aminopyridine treatment enhances intracortical glutamatergic transmission in progressive multiple sclerosis
    Gelibter, S.
    Pisa, M.
    Fichera, M.
    Giordano, A.
    Houdayer, E.
    Chieffo, R.
    Comi, G.
    Comola, M.
    Leocani, L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 282 - 282
  • [26] Enhancing Neural Transmission in Multiple Sclerosis (4-Aminopyridine Therapy)
    Goodman, Andrew D.
    Stone, Robert Thompson
    NEUROTHERAPEUTICS, 2013, 10 (01) : 106 - 110
  • [27] Protective effects of 4-aminopyridine in experimental optic neuritis and multiple sclerosis
    Dietrich, Michael
    Koska, Valeria
    Hecker, Christina
    Goettle, Peter
    Hilla, Alexander M.
    Heskamp, Annemarie
    Lepka, Klaudia
    Issberner, Andrea
    Hallenberger, Angelika
    Baksmeier, Christine
    Steckel, Julia
    Balk, Lisanne
    Knier, Benjamin
    Korn, Thomas
    Havla, Joachim
    Martinez-Lapiscina, Elena H.
    Sola-Valls, Nuria
    Manogaran, Praveena
    Olbert, Elisabeth D.
    Schippling, Sven
    Cruz-Herranz, Andres
    Yiu, Hao
    Button, Julia
    Caldito, Natalia Gonzalez
    von Gall, Charlotte
    Mausberg, Anne K.
    Stettner, Mark
    Zimmermann, Hannah G.
    Pau, Friedemann
    Brandt, Alexander U.
    Kuery, Patrick
    Goebels, Norbert
    Aktas, Orhan
    Berndt, Carsten
    Saidha, Shiv
    Green, Ari J.
    Calabresi, Peter A.
    Fischer, Dietmar
    Hartung, Hans-Peter
    Albrecht, Philipp
    BRAIN, 2020, 143 : 1127 - 1142
  • [28] Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine
    Baptista, Bruno Ribeiro
    Petitpain, Nadine
    Gomez, Emmanuel
    Yelehe-Okouma, Melissa
    Valentin, Simon
    Guillaumot, Anne
    Chabot, Francois
    Chaouat, Ari
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (01) : 127 - 129
  • [29] The effects of 4-aminopyridine on the pathophysiology of multiple sclerosis during thermal stress
    Davis, S.
    Remington, G.
    Frohman, T.
    Rola, K.
    Blazek, P.
    Korkmas, M.
    Abraham, T.
    Conger, A.
    Conger, D.
    Frohman, E.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S172 - S173
  • [30] Weak electromagnetic fields potentiate the effects of 4-aminopyridine in multiple sclerosis
    Sandyk, R
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1996, 85 (1-2) : 125 - 129
12345